摘要
目的探讨放射性125I粒子体外穿刺在治疗宫颈癌方面的技术可行性和疗效。方法 15例宫颈癌患者存局麻下实施经超声引导阴道穿刺125I粒子植入治疗,每颗粒子放射性活度为0．50-0．80 mCi,平均植入15颗。结果随访时间为3—6个月,全组患者随访期间除2例因全身衰竭死亡外,余均无复发,患者症状改善明显,思想压力明硅减轻,精神状况好,饮食改善。结论使用125I放射性粒子植入治疗宫颈癌,不受医疗资源的限制,操作简单,疗效确实可靠,放射并发症轻微,值得推广。
Objective To investigate the feasibility and therapeutic effects of ^125I particulate implantation in carcinoma of uterine cervix guided by ultrasonography. Methods Fifteen patients with carcinoma of uterine cervix were treated with ^125I particulate implantation guided by ultrasonography. The activity of ^125I sources ranged from 0.05 to 0.80 mCi, and the average number of ^125I sources were 15. Results 15 cases had partial or complete response during the following-up periods of 3 to 6 months, and the symptoms were obviously ameliorated, the mental pressure to carcinoma of uterine cervix was relieved. Conclusion ^125I particulate implantation in carcinoma of uterine cervix guided by ultrasonography is safe, minimal invasive and worthy of extending.
出处
《兰州大学学报（医学版）》
CAS
2006年第2期74-75,78,共3页
Journal of Lanzhou University（Medical Sciences）
关键词
^125I粒子
宫颈癌
植入
^125I particulate
carcinoma of uterine cervix
implantation
